C481
Showing 1 - 25 of 981
Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)
Not yet recruiting
- Chronic Kidney Disease
- +2 more
- Cagrilintide
- +2 more
-
Concord, California
- +73 more
Nov 9, 2023
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
-
Duarte, California
- +10 more
Jul 14, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +7 more
-
Manchester, United Kingdom
- +2 more
Aug 11, 2022
Chronic Lymphocytic Leukemia, Loss of Chromosome 17p Trial (Ibrutinib, Venetoclax)
Withdrawn
- Chronic Lymphocytic Leukemia
- Loss of Chromosome 17p
- (no location specified)
Oct 29, 2021
Papillomavirus Infections, Warts, Condylomata Acuminata Trial in Akron (PURELL VF481, Placebo Solution)
Completed
- Papillomavirus Infections
- +3 more
- PURELL VF481
- Placebo Solution
-
Akron, OhioAkron Dermatology
Jan 3, 2023
Acupuncture Trial in New York (Acupuncture)
Recruiting
- Acupuncture
- Acupuncture
-
New York, New YorkCardea Ketamine Space
Sep 30, 2023
Patient Perspectives in Mantle Cell Lymphoma Clinical Research
Not yet recruiting
- Mantle Cell Lymphoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 15, 2023
Central Venous Catheter Trial in Nidda (Ultrasound)
Completed
- Central Venous Catheter
- Ultrasound
-
Nidda, GermanyNeurologische Klinik Bad Salzhausen
Aug 10, 2022
Psoriatic Arthritis Trial in Worldwide (Placebo, Risankizumab)
Active, not recruiting
- Psoriatic Arthritis
- Placebo
- Risankizumab
-
Anniston, Alabama
- +255 more
Feb 23, 2022
Sport Related Concussion Trial (Bio-fluid analysis for the implementation of a diagnostic test for sport related concussion)
Not yet recruiting
- Sport Related Concussion
- Bio-fluid analysis for the implementation of a diagnostic test for sport related concussion
- (no location specified)
Nov 22, 2023
Drug Resistant Epilepsy Trial in Australia (ES-481, Placebo, Open-Label Extension Study)
Recruiting
- Drug Resistant Epilepsy
- ES-481
- +2 more
-
Herston, Queensland, Australia
- +3 more
Dec 12, 2021
Relapsing Multiple Scelrosis Trial in Worldwide (Ofatumumab subcutaneous injection, Teriflunomide-matching capsules,
Completed
- Relapsing Multiple Scelrosis
- Ofatumumab subcutaneous injection
- +3 more
-
Birmingham, Alabama
- +177 more
Oct 21, 2021
Activated Carbon Cloth Dressing and Silver-Based Dressing
Enrolling by invitation
- Diabetic Foot Ulcer
-
Cheras, Wilayah Persekutuan Kuala Lumpur, MalaysiaHospital Canselor Tuanku Muhriz UKM
Mar 27, 2023
Eating Disorders Trial (Family-based treatment)
Completed
- Eating Disorders
- Family-based treatment
- (no location specified)
Feb 8, 2023
Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)
Recruiting
- Diffuse Large B Cell Lymphoma
- +3 more
- Low-Dose Decitabine plus anti-PD-1
-
Beijing, Beijing, ChinaChinaPLAGH
Apr 18, 2023
Impacted Third Molar Tooth, Impacted Tooth Trial in Istanbul (Single-Session Bilateral Mandibular Third Molar Extraction,
Completed
- Impacted Third Molar Tooth
- Impacted Tooth
- Single-Session Bilateral Mandibular Third Molar Extraction
- Two-Session Bilateral Mandibular Third Molar Extraction
-
Istanbul, TurkeyMarmara University School of Dentistry
Apr 6, 2023
Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma Trial in Los Angeles (Biospecimen Collection, Magnetic Resonance
Recruiting
- Glioblastoma
- +2 more
- Biospecimen Collection
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Completed
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +128 more
Feb 14, 2022
Congenital Anomalies in Infants of Diabetic Mother
Not yet recruiting
- Congenital Abnormalities
- Echo_CT_MRI_US_x ray
- (no location specified)
May 23, 2022
Postoperative Pulmonary Atelectasis Trial in Nanjing (novel recruitment maneuver therapy)
Active, not recruiting
- Postoperative Pulmonary Atelectasis
- novel recruitment maneuver therapy
-
Nanjing, Nanjing, ChinaNanjing First Hospital
Sep 19, 2023